drugset / Trial / NCT02543203

Essential Oils for Enhancing QOL in ASD

NCT02543203

Phase 2 Completed 28 enrolled Jill Hollway Young Living Essential Oils · collab
RandomizedCrossoverQuadruple-blindSupportive care

Summary

Essential oils (aromatic oils extracted from plant parts) are routinely used by the public and are available on the market. Investigators are conducting this study because it is unknown whether the essential oils formulations will be safe and effective for improving quality of life in children with Autism Spectrum Disorder (ASD) by helping them relax and sleep. Children invited to participate in this study must be between 3-9 years of age and have been diagnosed with Autism Spectrum Disorder. Twenty eight children and their families will be enrolled in the study. Participants will try two different fragrant oils in a double-blind randomized order. Each child will receive each treatment for 3 months, with a 1-month "washout" period in between during which no oil is used.

Timeline

Start
2015-07
Primary completion
2018-03-16
Completion
2018-03-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Coconut oil Unknown Topical
Comparator Reconnect Unknown Topical